Pneumocystis jiroveci Prophylaxis with Rituximab
Portuguese Kidney Journal (PKJ) · 12.02.2025
DOI: 10.71749/pkj.78 ↗Kurz gefasst
Fachartikel in der Zeitschrift Portuguese Kidney Journal (PKJ), erschienen am 12.02.2025. Verfasst von Margarida Lampreia Gomes und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Pneumocystis jiroveci pneumonia (PJP) prophylaxis is highly effective in HIV patients. The objective of this study was to examine the efficacy and adverse effects of PJP prophylaxis among rituximab treated non–HIV patients.
Methods
We performed a systematic review based on the Preferred Reporting Items for Systematic Review and Meta‑Analyses (PRISMA) model.
Results
Eight retrospective studies were included with a combined cohort of 6048 patients. The most common prophylaxis drug used was trimethoprim/sulfamethoxazole (TMP‑SMX). There were 17 PJP infections in the prophylaxis arm against 147 in the control arm (incidence 0.3% vs 2.4%; OR, 0.35; 95% CI, 0.19‑0.64). The number needed to treat (NNT) to prevent 1 PJP episode was 36 patients (CER, 3.6%). The mortality rate due to PJP was 25%. All ADRs (adverse drug reactions) resolved with TMP‑SMX discontinuation.
Conclusion
Prophylaxis with TMP‑SMX seems justifiable in combined therapies with rituximab. But in monotherapy, the results are not robust. The decision should be patient‑based. The optimal duration of prophylaxis is also unclear.
Schlagwörter
Zitieren
APA
Gomes, M. L., Godinho, I., Gameiro, J., & Lopes, J. A. M. (2025). Pneumocystis jiroveci Prophylaxis with Rituximab. Portuguese Kidney Journal (PKJ). https://doi.org/10.71749/pkj.78
Vancouver
Gomes ML, Godinho I, Gameiro J, Lopes JAM. Pneumocystis jiroveci Prophylaxis with Rituximab. Portuguese Kidney Journal (PKJ). 2025. doi:10.71749/pkj.78
BibTeX
@article{Gomes2025,
author = {Gomes, Margarida Lampreia and Godinho, Iolanda and Gameiro, Joana and Lopes, José António Machado},
title = {Pneumocystis jiroveci Prophylaxis with Rituximab},
journal = {Portuguese Kidney Journal (PKJ)},
year = {2025},
doi = {10.71749/pkj.78}
}
EUVIMED